These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38949568)

  • 1. LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy.
    Sharma A; Chowdhury S; Mukherjee S; Chowdhury R
    Biol Cell; 2024 Sep; 116(9):e2400034. PubMed ID: 38949568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA
    Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
    Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
    Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T
    Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
    Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
    J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma.
    New M; Van Acker T; Sakamaki JI; Jiang M; Saunders RE; Long J; Wang VM; Behrens A; Cerveira J; Sudhakar P; Korcsmaros T; Jefferies HBJ; Ryan KM; Howell M; Tooze SA
    Cancer Res; 2019 Apr; 79(8):1884-1898. PubMed ID: 30765601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.
    Jia Y; Li HY; Wang Y; Wang J; Zhu JW; Wei YY; Lou L; Chen X; Mo SJ
    Int J Biol Sci; 2021; 17(11):2772-2794. PubMed ID: 34345207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine.
    Li Y; Wang X; Yu H; Cao J; Xie J; Zhou J; Feng Z; Chen W
    Mol Carcinog; 2024 Oct; 63(10):1953-1966. PubMed ID: 39016677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer.
    Sun T; Peng H; Mao W; Ma L; Liu H; Mai J; Jiao L
    Int J Biol Sci; 2021; 17(13):3634-3645. PubMed ID: 34512171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
    Gopal U; Mowery Y; Young K; Pizzo SV
    J Biol Chem; 2019 Sep; 294(38):13939-13952. PubMed ID: 31358620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.
    Zhang W; Nandakumar N; Shi Y; Manzano M; Smith A; Graham G; Gupta S; Vietsch EE; Laughlin SZ; Wadhwa M; Chetram M; Joshi M; Wang F; Kallakury B; Toretsky J; Wellstein A; Yi C
    Sci Signal; 2014 May; 7(324):ra42. PubMed ID: 24803537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
    Nai Y; Pan C; Hu X; Ma Y
    Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation.
    Cai X; Chen F; Tang H; Chao D; Kang R; Tang D; Liu J
    Int J Biochem Cell Biol; 2024 Oct; 175():106646. PubMed ID: 39179170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.
    Luo Z; Yi ZJ; Ou ZL; Han T; Wan T; Tang YC; Wang ZC; Huang FZ
    J Cell Physiol; 2019 Apr; 234(4):3583-3597. PubMed ID: 30362505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.
    Zhao C; Gong J; Bai Y; Yin T; Zhou M; Pan S; Liu Y; Gao Y; Zhang Z; Shi Y; Zhu F; Zhang H; Wang M; Qin R
    Cell Death Differ; 2023 Jan; 30(1):1-15. PubMed ID: 35906484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
    Hao F; Xu Q; Wang J; Yu S; Chang HH; Sinnett-Smith J; Eibl G; Rozengurt E
    PLoS One; 2019; 14(5):e0216603. PubMed ID: 31100067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway.
    Ma H; Kong L; Liu L; Du Y; Zhu X; Wang J; Zhao W
    Mol Carcinog; 2024 Jul; 63(7):1221-1234. PubMed ID: 38517039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.